Expressive writing workshop for young adults with blood cancer
An Expressive Writing Program to Support Emotional Wellness Among Young Adults With Hematologic Malignancy
This project tries to see if a four-week online expressive writing workshop helps mental wellness for young adults (ages 18–39) with blood cancer and their informal caregivers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Blood Cancer United Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT07413991 on ClinicalTrials.gov |
What this trial studies
This randomized, waitlist-controlled program delivers a four-week online expressive writing workshop with weekly prompts and a minimum 15-minute writing task each week. Participants are randomly assigned to start immediately or after a four-week wait, and all complete three surveys over a 12-week period to track changes in mental wellness. Sharing writing in a private online community is optional. Researchers will compare mental wellness changes between the immediate and delayed start groups.
Who should consider this trial
Good fit: Ideal participants are adults aged 18–39 who have a hematologic malignancy (in treatment or post-treatment) or the informal caregivers of such young adults, who live in the U.S., Canada, or U.S. territories and can read and write English.
Not a fit: People under 18, those living outside the U.S., Canada, or their territories, or those who cannot read or write English would not be eligible and therefore would not be expected to benefit from participating.
Why it matters
Potential benefit: If helpful, the workshop could offer a low-cost, accessible way to improve mood and coping for young adults with blood cancer and their caregivers.
How similar studies have performed: Previous expressive writing programs in cancer and other chronic illness groups have produced modest improvements in emotional well-being, though results vary and the young-adult blood cancer subgroup has been less studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with a hematologic malignancy diagnosis in treatment or after treatment is completed, who is currently between the ages of 18 and 39 (young adult), or the informal caregiver of a young adult blood cancer patient * Located within the U.S., Canada, or U.S. territories * Able to read and write in English Exclusion Criteria: * Located outside of the U.S., Canada, or its territories * Participant is a minor aged 17 years or below
Where this trial is running
Washington D.C., District of Columbia
- Blood Cancer United — Washington D.C., District of Columbia, United States (Recruiting)
Study contacts
- Study coordinator: Research Coordinator
- Email: researchprograms@bloodcancerunited.org
- Phone: 914-821-8862
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.